ConductScience.org, home

Paper9738873

Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease.

Martiniuk F and 10 others. Am J Med Genet, 1998. Cited by 154 papers, by iCite.

Cite this record

ConductScience Library. Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease. Papers, record 9738873. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9738873

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease.
PubMed
Journal
Am J Med Genet
PubMed
Year
1998
PubMed
Publication types
Letter, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
154
iCite
Relative citation ratio, by iCite
4.25
iCite
Revised in PubMed
2022-04-10
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Martiniuk FF
2Chen AA
3Mack AA
4Arvanitopoulos EE
5Chen YY
6Rom WNW N
7Codd WJW J
8Hanna BB
9Alcabes PP
10Raben NN
11Plotz PP

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Glycogen Storage Disease Type IIMajor topic
HeterozygoteMajor topic
Adolescent
Adult
Aged
Aged, 80 and over
Child
Child, Preschool
Female
Humans
Infant
Infant, Newborn
Male
Middle Aged
New York

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
MO1 RR00096NCRR NIH HHSUnited StatesM01RR000096PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02838368Investigating Pompe Prevalence in Neuromuscular Medicine Academic PracticesBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by75

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 154 citations.

PMIDTitleJournalYearIn PapersSource
41586257Beginning of a new era of synthetic messenger RNA therapeutics: Comprehensive insights on mRNA drug design, development and applications.Exp Biol Med (Maywood)2025https://conductscience.org/library/papers/41586257PubMed
40969949Correction of Disease Phenotype in Pompe Disease Knockout Mice Following Cationic Lipid-GL-67-Mediated Gene Therapy.DNA Cell Biol Rep2025https://conductscience.org/library/papers/40969949PubMed
40524065Clinical and therapeutic clues from a long-term follow-up: a single center experience on a large LOPD population.J Neurol2025https://conductscience.org/library/papers/40524065PubMed
40502951Successful Pregnancy Outcome in Patient with Pompe Disease Despite Discontinuation of Enzyme Replacement Therapy.Eur J Case Rep Intern Med2025https://conductscience.org/library/papers/40502951PubMed
40329343Global variations in diagnostic methods and epidemiological estimates in Pompe disease: findings from a scoping review.Orphanet J Rare Dis2025https://conductscience.org/library/papers/40329343PubMed
40225932Biochemical and Genetic Testing of GAA in Over 30.000 Symptomatic Patients Suspected to Be Affected With Pompe Disease.Hum Mutat2024https://conductscience.org/library/papers/40225932PubMed
39457174Effectiveness of Respiratory Muscle Training in Pompe Disease: A Systematic Review and Meta-Analysis.Children (Basel)2024https://conductscience.org/library/papers/39457174PubMed
39273088Mutation Spectrum of GAA Gene in Pompe Disease: Current Knowledge and Results of an Italian Study.Int J Mol Sci2024https://conductscience.org/library/papers/39273088PubMed
38361118Global carrier frequency and predicted genetic prevalence of patients with pathogenic sequence variants in autosomal recessive genetic neuromuscular diseases.Sci Rep2024https://conductscience.org/library/papers/38361118PubMed
38274468An analysis of Pompe newborn screening data: a new prevalence at birth, insight and discussion.Front Pediatr2023https://conductscience.org/library/papers/38274468PubMed
37907381Variant Classification for Pompe disease; ACMG/AMP specifications from the ClinGen Lysosomal Diseases Variant Curation Expert Panel.Mol Genet Metab2023https://conductscience.org/library/papers/37907381PubMed
37759679A Comprehensive Update on Late-Onset Pompe Disease.Biomolecules2023https://conductscience.org/library/papers/37759679PubMed
36969713Pompe Disease: a Clinical, Diagnostic, and Therapeutic Overview.Curr Treat Options Neurol2022https://conductscience.org/library/papers/36969713PubMed
36245745Infantile-onset Pompe disease complicated by sickle cell anemia: Case report and management considerations.Front Pediatr2022https://conductscience.org/library/papers/36245745PubMed
35747179Clinical characteristics and survival of children with hypertrophic cardiomyopathy in China: A multicentre retrospective cohort study.EClinicalMedicine2022https://conductscience.org/library/papers/35747179PubMed
35264382Non-specificity of symptoms in infantile-onset Pompe disease may delay the diagnosis and institution of treatment.BMJ Case Rep2022https://conductscience.org/library/papers/35264382PubMed
34501319Molecular Diagnosis of Pompe Disease in the Genomic Era: Correlation with Acid Alpha-Glucosidase Activity in Dried Blood Spots.J Clin Med2021https://conductscience.org/library/papers/34501319PubMed
34353347Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy.Orphanet J Rare Dis2021https://conductscience.org/library/papers/34353347PubMed
34020684Genotype-phenotype correlation of 17 cases of Pompe disease in Spanish patients and identification of 4 novel GAA variants.Orphanet J Rare Dis2021https://conductscience.org/library/papers/34020684PubMed
33717985Carrier frequency and predicted genetic prevalence of Pompe disease based on a general population database.Mol Genet Metab Rep2021https://conductscience.org/library/papers/33717985PubMed

See all 75 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9738873

GET https://conductscience.org/api/papers/v1/9738873/cited_by?page=2